Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study ESPER: Blood-sparing During the Placement of a Total Hip Prosthesis With the Exacyl® in Patients Treated With Rivaroxaban, Phase IV

NCT02403596 is registered in ClinicalTrials.gov with University Hospital, Brest as lead sponsor.

NCT NCT02403596
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02403596 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study ESPER: Blood-sparing During the Placement of a Total Hip Prosthesis With the Exacyl® in Patients Treated With Rivaroxaban, Phase IV
Lead sponsor
University Hospital, Brest
Phase
Phase 3
Overall status
Completed
Start date
October 20, 2015
Completion date
August 29, 2017
Enrollment
231 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

blood loss after a total hip replacement